VIROPHARMA INC

SEC insider activity covers quarterly filings through June 30, 2026. Later filings are not included. Reported roles do not establish current employment or current holdings. SEC filing documents, sections and filing-text search cover filings dated January 1, 2000 onward. Earlier filings are deferred until after launch.

organization

SEC Insider

$325.0M

1,349 transactions

Summary

VIROPHARMA INC is an organization.

Recent Insider Transactions

As filed, including amendments; not net cash flow or current holdings. Joint reports count once. Totals cover known values only.

Buys: $116.3MSales: $77.7M30 insiders

Date	Insider	Type	Value
2014-01-24	Broom Colin MD(VP & Chief Scientific Officer)	U	$7.7M
2014-01-24	Broom Colin MD(VP & Chief Scientific Officer)	D	—
2014-01-24	Broom Colin MD(VP & Chief Scientific Officer)	D	—
2014-01-24	Broom Colin MD(VP & Chief Scientific Officer)	D	—
2014-01-24	Broom Colin MD(VP & Chief Scientific Officer)	D	—
2014-01-24	Broom Colin MD(VP & Chief Scientific Officer)	D	—
2014-01-24	Broom Colin MD(VP & Chief Scientific Officer)	D	—
2014-01-24	Broom Colin MD(VP & Chief Scientific Officer)	D	—
2014-01-24	Broom Colin MD(VP & Chief Scientific Officer)	D	—
2014-01-24	Broom Colin MD(VP & Chief Scientific Officer)	D	—
2014-01-24	Broom Colin MD(VP & Chief Scientific Officer)	D	—
2014-01-24	Broom Colin MD(VP & Chief Scientific Officer)	D	—
2014-01-24	Broom Colin MD(VP & Chief Scientific Officer)	D	—
2014-01-24	Broom Colin MD(VP & Chief Scientific Officer)	D	—
2014-01-24	Broom Colin MD(VP & Chief Scientific Officer)	A	—
2014-01-24	Broom Colin MD(VP & Chief Scientific Officer)	D	—
2014-01-24	DOYLE THOMAS F(VP Strategic Initiatives)	D	—
2014-01-24	DOYLE THOMAS F(VP Strategic Initiatives)	D	—
2014-01-24	DOYLE THOMAS F(VP Strategic Initiatives)	D	—
2014-01-24	DOYLE THOMAS F(VP Strategic Initiatives)	D	—

SEC filings: SEC EDGAR

Activity data: SEC EDGAR

VIROPHARMA INC — Contributions, Lobbying & Contracts | Poliscope